Given SAMD9’s role in antivirus and antitumor responses, and its potential as an IFN-response gene, we sought to comprehensively investigate its expression pattern and clinicopathological significance in IDH-wildtype glioblastoma. The gene discussed is SAMD9; the disease is glioblastoma.